Litigation
at Munich (DE) Central Division - Section
46 litigation decisions from Munich (DE) Central Division - Section.
Litigation Decisions
46 cases | Page 2 of 2
Sanofi v.Amgen, Regeneron
Unified Patent Court decision.
NanoString Technologies Europe Limited v.President and Fellows of Harvard College
This is a revocation action brought by NanoString Technologies Europe Limited against President and Fellows of Harvard College concerning European patent EP 2 794 928 B1 before the Central Division (Section Munich) of the Unified Patent Court. Following an interim conference held on 25 January 2024, the judge-rapporteur issued an order addressing procedural matters, including the admission of late-filed prior art document D46, the value of the proceedings, and the confirmation of the oral hearing date.
NanoString Technologies Europe Limited v.President and Fellows of Harvard College
Unified Patent Court decision.
NanoString Technologies Europe Limited v.President and Fellows of Harvard College
This is a revocation action brought by NanoString Technologies Europe Limited against President and Fellows of Harvard College concerning European patent EP 2 794 928 B1 before the Court of First Instance of the Unified Patent Court (Central Division, Section Munich). Following an interim conference held on 25 January 2024, the judge-rapporteur issued an order addressing procedural matters including the admission of late-filed document D46, the value of the proceedings, and the confirmation of the oral hearing date. The Court admitted document D46 into the proceedings, set the value of the proceedings at EUR 7,500,000, and confirmed the oral hearing for 17 April 2024.
Sanofi-Aventis Deutschland GmbH v.Amgen, Inc.
Unified Patent Court decision.
Mathys & Squire v.Astellas, Healios, Riken, Osaka University
Unified Patent Court decision.
ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE v.HELIOS K.K, OSAKA UNIVERSITY
Unified Patent Court decision.
ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE v.HELIOS K.K, OSAKA UNIVERSITY
Unified Patent Court decision.
President and Fellows of Harvard College v.NanoString Technologies Europe Limited
Unified Patent Court decision.
ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE v.HELIOS K.K, RIKEN, OSAKA UNIVERSITY
Unified Patent Court decision.
ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE v.HELIOS K.K, RIKEN
Unified Patent Court decision.
President and Fellows of Harvard College v.NanoString Technologies Europe Limited
Unified Patent Court decision.
ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE v.HEALIOS K.K, RIKEN, OSAKA UNIVERSITY
Unified Patent Court decision.
Amgen, Inc. v.Sanofi-Aventis Deutschland GmbH
Unified Patent Court decision.
Amgen, Inc. v.Sanofi-Aventis Deutschland GmbH
Unified Patent Court decision.
Sanofi-Aventis Deutschland GmbH v.Amgen, Inc.
Unified Patent Court decision.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.